According to TechSci Research report, “Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, […]
Pharmaceuticals
The Himalaya Drug Company shares results of a clinical study that evaluated the role of herbal immunomodulators as an adjuvant treatment in the management of COVID-19
The Himalaya Drug Company, India’s leading wellness brand, shared the results of the clinical study they commissioned to evaluate the role of their well-known herbal products (Tab. Septilin and Tab. Bresol in combination) as an adjuvant treatment in mildly symptomatic and asymptomatic COVID-19–positive patients. The clinical trial was conducted under […]
Inventia calls on Baker Dillon Group to introduce Nutriventia brand in the U.S.A.
India-based Inventia Healthcare Limited, a three-decade young pharmaceutical company built on the ethos of developing products with novel drug delivery platforms, has launched its new brand, Nutriventia, providing innovative nutraceutical ingredient solutions through extensive technical expertise and scientific research to enable industry brands to bring various finished formulations and claims […]
Dr. Reddy’s to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for […]
US-FDA Approved Foundation Medicine’s FoundationOne®Liquid CDx, a Pan-Tumor Liquid Biopsy Genomic Test for Late Stage Cancer Patients now Available in India
Roche Products (India) Pvt. Ltd. (Roche Pharma India) announces the launch of FoundationOne®Liquid CDx, Foundation Medicine’s comprehensive pan-tumor liquid biopsy test for patients with solid tumors in India. US FDA approved the FoundationOne®Liquid CDx, a comprehensive genomic profiling (CGP) test on August 26. This is the first test that can […]
The Himalaya Drug Company Introduces Q-DEE Range of Mouth Dissolving Tablets for Immunity and Cramps
The Himalaya Drug Company, one of India’s leading wellness brands, announces the launch of Q-DEE Mouth Dissolving Tablets ─ Q-DEE Immunity and Q-DEE Cramps. Q-DEE Immunity helps provide relief from the early onset of flu and common cold symptoms such as sore throat, cough, sneezing, and nasal congestion. It also […]
The Himalaya Drug Company launches ‘Ab Daant Hamesha 10/10’ campaign through its new film for Himalaya Complete Care Toothpaste
The Himalaya Drug Company, one of India’s leading wellness brands, launched a new film under their ‘Ab Daant Hamesha 10/10′ campaign. This new campaign for Himalaya Complete Care Toothpaste focuses on the importance of using the right toothpaste to prevent toothache and cavities and bring happiness in our daily lives. The film features […]
Herbostra: Modernizing Conventional Ayurvedic Products
As a wellness brand, Herbostra believes in balancing the mind, body and soul and strive to formulate products that encircle the belief to modernize conventional Ayurvedic products. Their products are curated using the standardized procedure of infusing pure herbs and advanced techniques that are tested by niche experts. Their unique products are […]
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf®1 Capsules, 0.5 mg, 1 mg and 5 mg, of Astellas Pharm US, Inc. According to IQVIATM sales […]
Jubilant Pharma Ltd. and Aavis Pharmaceuticals launch Hydroxychloroquine Sulfate tablets in the U.S. market
Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. announce the launch of Hydroxychloroquine Sulfate tablets, 200 mg, a therapeutic equivalent version of Plaquenil (hydroxychloroquine sulfate) 200 mg in the U.S. market. The product will be distributed by Jubilant Cadista, a unit of Jubilant Pharma Ltd. Hydroxychloroquine Sulfate Tablets are indicated for the […]
